Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of New Drugs
1003-3734
2015 Issue 15
Incentives for orphan drugs R&D in Europe and America and the enilghtenment for China
WANG Hong;WU Zhi-ang;School of Business Administration;Shenyang Pharmaceutical University;
..............page:1681-1685+1693
Investigation and analysis of healthcare patents distribution and trend
ZHU Xiu-huang;YI Xiang-hua;XUE Fang-fang;LI Qiong;Beijing Pharma and Biotech Center;Beijing Incoshare Co.;Ltd.;
..............page:1686-1693
Analysis of patent layout by Sanofi Aventis pharmaceutical company in China
YANG Shu-jie;HUA Si-hua;YUAN Hong-mei;LIAN Gui-yu;School of Business Administration;Shenyang Pharmaceutical University;
..............page:1694-1697
Analysis of patent application of the new HCV inhibitor sofosbuvir in China
MAO Dan;Patent Examination Cooperation Jiangsu Center of Patent Office;
..............page:1698-1701
Research progress of in vitro systems for neurotoxicity evaluation
QU Zhe;L Jian-jun;LIN Zhi;HUO Gui-tao;YANG Yan-wei;ZHANG Di;ZHANG Shuo;LI Shan-shan;WANG Xue;WANG Ju-feng;LI Bo;National Center for Safety Evaluation of Drugs;National Institutes for Food and Drug Control;
..............page:1702-1706
Determination of insulin precursor in recombinant human insulin by RP-HPLC
DING Xiao-li;GE Yu-peng;ZHANG Hui;LIANG Cheng-gang;National Institutes for Food and Drug Control;China Pharmaceutical University;
..............page:1707-1710
Preparation and antibacterial activity of antimicrobial peptide CA gel
LIU Chao-yong;XIAO Yun-zhi;LI Xiao-rong;WAN Lu;LI Rui-sheng;HAN Jin;YUAN Hai-long;302 Military Hospital of China;Chengdu University of Traditional Chinese Medicine;
..............page:1711-1714+1719
A method for determination of biological activity of PCSK9 monoclonal antibody
LIU Chun-yu;ZHU Lei;ZHANG Feng;YU Chuan-fei;WANG Wen-bo;LI Meng;CHEN Wei;WANG Lan;GAO Kai;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products;Chinese Nationol Institute for Food and Drug Control;
..............page:1715-1719
Anti-IgD antibody and its role in autoimmune diseases
CHEN Heng-shi;WU Yu-jing;HUANG Qiong;CHEN Wen-sheng;WEI Wei;Institute of Clinical Pharmacology;Anhui Medical University;Key Laboratory of Anti-inflammatory and Immune Medicine;Ministry of Education;Collaborative Innovation Center of Anti-inflammatory and Immune Medicine in Anhui Province;
..............page:1720-1723+1741
Discussion on investigation of foreign matter introduced by parenteral manufacturing process
LI Da-wei;HUANG Shao-feng;ZHENG Qiang;SUN Jing-lin;Center for Pharmaceutical Information and Engineering Research;Peking University;Department of Industry Engineering and Management;College of Engineering;Peking University;Ausia Biological Technology Company;Ltd;Center for Food and Drug Inspection of China Food and Drug Administration;
..............page:1724-1726+1753
Current situation and the trend in impurity profiling of chemical drugs
HU Chang-qin;National Institutes for Food and Drug Control;
..............page:1727-1734
Advance in study of long-acting glucagon-like peptide-1 receptor agonists
LIN Xuan;WANG Jun-ling;LI Tai-ming;WU Yan-zhuo;XU Ming-bo;College of Life Science and Technology;China Pharmaceutical University;Beijing SL Pharmaceutical Co.;Ltd.;
..............page:1735-1741
MRI-based dual molecular imaging techniques and theranostics
JIANG Dan-dan;ZHANG Na;School of Pharmaceutical Science;Shandong University;
..............page:1742-1746+1776
Interpretation of “Good Clinical Practice(revised draft) ”
ZHAO Ying-pan;LU Fang;ZI Ming-jie;LI Rui;LI Bo;LI Qing-na;ZHAO Yang;GAO Rui;Clinical Pharmacology Institute;Xiyuan Hospital;China Academy of Chinese Medical Sciences;
..............page:1747-1749+1785
Comparison and analysis of issues existing in informed consent forms of clinical trials sponsored by foreign and domestic enterprises
BAI Cai-zhen;FAN Xiao;REN Pei-juan;LI Na;Presidents’ Office;Beijing Tiantan Hospital;Capital Medical University;Department of Research;Beijing Tiantan Hospital;Capital Medical University;
..............page:1750-1753
Research on protection of paticipants’ rights and interests in clinical trials:a case study of a clinical trial agency of one 3A grade hospitals in Beijing
ZHENG Jun;LI Yi-ting;Office of Education and Research;Beijing Ditan Hospital;Capital Medical University;Capital Medical University;
..............page:1754-1759
Clinical efficacy of crizotinib for brain metastases in patients with advanced ALK-rearranged non-small cell lung cancer
LIU Yu-tao;WANG Zi-ping;HU Xing-sheng;LI Jun-ling;HAO Xue-zhi;SHI Yuan-kai;Department of Medical Oncology;Cancer Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
..............page:1760-1764+1770
Synthesis and biological evaluation of novel phenylacetamides analogs as histone acetylation enzyme inhibitors
JIA Zhong;ZHANG Yang;LI Jing;ZHAO Jing-si;XI Na;MA Shang-xian;HE Dian;Lanzhou Pulmonary Hospital Pharmacy;Institute of Medicinal Chemistry;School of Pharmaceutical Science;Lanzhou University;
..............page:1765-1770
In vitro evaluation of RGD peptide-modified polyglutamic acid-cisplatin conjugate
XIONG Ye-rong;TU Jia-sheng;LIU Kai-shuang;ZHANG Meng-ze;Department of Pharmaceutics;China Pharmaceutical University;
..............page:1771-1776
Preparation and in vitro evaluation of raloxifene hydrochloride self-microemulsion
LU Xiu-xia;LI Wei-zhen;HE Lin;LUO Hai-shan;PAN Yu-fang;College of Chemistry and Chemical Engineering;Guangdong Pharmaceutical University;Guangdong Province the First Veterans Hospital;
..............page:1777-1785
Quantitative analysis of multi-components of Shanlvcha Jiangya capsules by combining HPLC fingerprint with QAMS method
YIN Rui-zhuo;WANG Jia-yi;BAO Yong-rui;WANG Shuai;MENG Xian-sheng;College of Pharmacy;Liaoning University of Traditional Chinese Medicine;Liaoning Province Component of Traditional Chinese Medicine and Engineering Research Center;Liaoning Province Modern Traditional Chinese Medicine Research and Engineering Laboratory;Liaoning Institute for Drug Control;
..............page:1786-1790+1794
Evaluation of vascular irritation of paricalcitol injection
LI Bei;ZHOU Ying;ZHANG Xing;ZHAO Ying-shu;Hainan Provincial Institute for Food and Drug Control;
..............page:1791-1794
Literature summary and data analysis of hypophosphatemia and osteomalacia caused by adefovir dipivoxil treatment for patients with hepatitis B
ZHANG Shuai;FANG Shu-shu;CAO Guo-ying;Department of Pharmacy;Beijing Hospital;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Sciences;Peking University;
..............page:1795-1800